TB-500Also known as: Thymosin Beta-4
TL;DR — What is TB-500?
TB-500 is a synthetic fragment of Thymosin Beta-4 (Tβ4), a 43-amino-acid peptide that occurs naturally in high concentrations at injury sites and in blood platelets. Unlike BPC-157 which works primarily through local angiogenesis, TB-500 promotes systemic healing by enhancing cell migration, reducing inflammation, and upregulating proteins involved in tissue repair. It is particularly valued for its ability to heal injuries throughout the body from a single injection site, making it a cornerstone of the 'Wolverine Healing Stack' alongside BPC-157.
Primary Function: Systemic tissue repair via cell migration and anti-inflammatory effects
Legal Status (US): Not FDA-approved; WADA prohibited substance; unscheduled research chemical
Fast Stats
How TB-500 Functions in a Stack
Mechanism of Action
TB-500 works through fundamentally different mechanisms than BPC-157, which is why the two are so often stacked together. Understanding these mechanisms explains TB-500's unique systemic healing properties.
Actin Sequestration and Cell Migration
The primary mechanism of Thymosin Beta-4 is its interaction with G-actin, a building block of the cellular cytoskeleton. By sequestering G-actin, TB-500 promotes cell motility and migration—allowing stem cells, keratinocytes, and endothelial cells to travel to injury sites more efficiently.
This explains why TB-500 works systemically: it doesn't need to be injected near the injury because it enhances the body's natural ability to move healing cells to wherever they're needed.
Anti-Inflammatory Effects
TB-500 demonstrates potent anti-inflammatory properties through multiple pathways:
- Downregulation of pro-inflammatory cytokines (IL-1β, TNF-α)
- Reduction of oxidative stress markers
- Inhibition of NF-κB inflammatory signaling
Upregulation of Repair Proteins
TB-500 increases production of proteins essential for tissue repair, including laminin and fibronectin—components of the extracellular matrix that provide scaffolding for new tissue growth.
TB-500 vs BPC-157
- TB-500: Systemic healing, cell migration, long half-life, anti-inflammatory
- BPC-157: Local healing, angiogenesis, short half-life, growth factor modulation
- Together: Complementary mechanisms for comprehensive injury recovery
Evidence Base
Thymosin Beta-4 has been studied extensively, including in human clinical trials for conditions like dry eye, wound healing, and cardiac repair post-myocardial infarction. This gives TB-500 a stronger human evidence base than many peptides, though the specific fragment used as "TB-500" may differ from pharmaceutical Tβ4.
Human Studies
- Cardiac repair: Phase II trials showed improved cardiac function post-MI
- Dry eye: Approved (as RGN-259) for neurotrophic keratitis in some regions
- Wound healing: Multiple trials on chronic wound healing with positive results
Animal Studies
Animal research shows TB-500/Tβ4 effectiveness for:
- Tendon and ligament repair (accelerated healing in multiple models)
- Muscle regeneration (enhanced myoblast differentiation)
- Hair regrowth (stimulated hair follicle stem cells)
- Neurological protection and repair
Protocols and Dosing
Standard Healing Protocol
TB-500 protocols typically involve a loading phase followed by maintenance:
- Loading Phase (4-6 weeks): 2-2.5mg twice per week (4-5mg total weekly)
- Maintenance Phase: 2-2.5mg once per week
- Duration: 8-12 weeks total for significant injuries
Injection Protocol
Unlike BPC-157, TB-500 does not need to be injected near the injury site. Its systemic mechanism means you can inject anywhere convenient:
- Subcutaneous in the abdominal area (most common)
- Intramuscular if preferred
- Rotate injection sites to prevent lipodystrophy
Stacking Protocol
Stack Synergies
TB-500 + BPC-157 (The Wolverine Stack)
The combination of TB-500 and BPC-157 is the gold standard for injury recovery:
- TB-500: 2-2.5mg twice weekly (systemic healing, cell migration)
- BPC-157: 250-500mcg daily near injury site (local angiogenesis)
- Duration: 6-12 weeks depending on injury severity
Full protocol details: Injury Repair Stack Guide
TB-500 + GH Peptides
Adding CJC-1295 or Ipamorelin provides IGF-1 elevation that further supports tissue repair, particularly for muscle injuries.
Side Effects and Safety
TB-500 has a favorable safety profile based on Thymosin Beta-4 human trials and extensive anecdotal use.
Reported Side Effects
- Flu-like symptoms: Occasionally reported in first 1-2 weeks (headache, fatigue)
- Injection site reactions: Mild redness or irritation
- Lethargy: Some users report temporary tiredness during loading
WADA Prohibition
Competitive Athletes
Frequently Asked Questions
What is TB-500 used for?
TB-500 is used for systemic tissue repair, wound healing, and recovery from injuries. It promotes cell migration, reduces inflammation, and supports healing of muscles, tendons, ligaments, and skin.
How is TB-500 different from BPC-157?
TB-500 works systemically to promote cell migration and reduce inflammation throughout the body, while BPC-157 works more locally through angiogenesis and growth factor modulation. They are often stacked together for complementary healing effects.
What is the standard TB-500 dosage?
The typical loading dose is 2-2.5mg twice per week for 4-6 weeks, followed by a maintenance dose of 2-2.5mg once per week.
Is TB-500 legal?
TB-500 is not FDA-approved and is banned by WADA for competitive athletes. It is available as a research chemical in the US but is not approved for human use.
Bottom Line on TB-500
Medical Disclaimer
This content is for educational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting any hormone therapy or peptide protocol. Never self-prescribe or adjust dosages without professional guidance.